PDF
File
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
"We are leaving behind a quarter of growth and improved profitability in line with our ambitions, as well as a strong cash flow. Rental and service performed well globally and we are continuing to see signs of a gradual improvement in the US, despite a challenging market situation. With high activity levels, we continue our efforts to strengthen Arjo's positions in both the short and the long term," says Joacim Lindoff, President and CEO of Arjo.
July-September 2023 in brief- Net sales increased to SEK 2,777 M (2,519).
- Adjusted EBITDA increased 19.8% to SEK 504 M (420).
- Adjusted operating profit increased 41.2% to SEK 207 M (147).
- Profit after financial items rose to SEK 130 M (115).
- Earnings per share increased to SEK 0.36 (0.32).
- Cash flow from operations rose to SEK 598 M (280), corresponding to a cash conversion of 120.8% (67.7).
- Launch of Evenda - a new bed customized for people living with dementia, which is estimated to affect more than 60% of long-term care residents.
Telephone conference
Fund managers, analysts and media are invited to participate in a conference call and presentation of the report on October 19 at 08.00 CEST via the following link: https://ir.financialhearings.com/arjo-q3-2023
Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration:
https://conference.financialhearings.com/teleconference/?id=5004761
Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2023/
A recorded version of the conference is accessible for three years via the following link:
https://ir.financialhearings.com/arjo-q3-2023
For more information, please contact:
Maria Nilsson, EVP Communications & Public Relations
Tel: +46 734 244 515
Email: maria.nilsson@arjo.com
Sara Ehinger, VP Investor Relations & Corporate Communications
Tel: +46 723 597 794
Email: sara.ehinger@arjo.com
This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on October 19, 2023.
About Arjo
At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com